- This event has passed.
18.00 – Registration over tea and coffee in the Roberts Foyer (Roberts Building, UCL)
18.25 – Walk to the Darwin Lecture Theatre (Darwin Building, UCL)
18.30 – Welcome – Dr. Stephen Ward (Cell Therapy Catapult) and Dr. Emily Culme-Seymour (LRMN)
18.35 – Process Improvements for Engineered T-cell Manufacture to Enable Near-Term Commercialisation – Dr. Daniel Williams, Adaptimmune Ltd. (Abingdon, UK)
19.05 – Q & A
19.10 – Technology Platforms for Large-Scale Manufacturing of Cell Therapies – Dr. Kim Warren, Lonza, Inc. (Walkersville, MD, US)
19.40 – Q & A
19.45 – Adult Adherent Stem Cell Therapy for Stroke: Anticipating Commercial Scale Manufacturing – Dr. Robert Deans, Athersys Inc. (Cleveland, OH, US)
20.15 – Q & A
20.20 – Closing remarks – Dr. Stephen Ward (Cell Therapy Catapult) and Professor Chris Mason (Advanced Centre for Biochemical Engineering, UCL)
20.25 – 22.00 – LRMN Reception – Network whilst enjoying a glass of wine or two in the Roberts Foyer (Roberts Building, UCL)
SPONSORS + PARTNERS
CORPORATE SPONSOR: Cell Therapy Catapult
PROMOTIONAL SUPPORT: ‘Regenerative Medicine‘
PLEASE NOTE THAT DUE TO LECTURE THEATRE SEATING CAPACITY, IF YOU WISH TO ATTEND THIS EVENT YOU MUST REGISTER AS REQUESTED, OTHERWISE UNFORTUNATELY YOU WILL NOT BE ABLE TO GAIN ADMISSION. Seat allocation is on a first come, first served basis. If you wish to attend, all that is required is to email email@example.com and type ‘I will attend’ in the subject box. Please only register if you can definitely make the meeting. If you have to cancel later do please let us know.
The LRMN Team very much look forward to welcoming attendees for this event that will focus on the very latest in cell therapy manufacturing.